Learn More
Seracare Life Sciences Inc Seraseq ctDNA Mutation Mix V4 AF5%, Highly Multiplexed Reference Material, 93 Clinically Relevant Variants, 25 µL
Supplier: Seracare Life Sciences Inc 07103100
Seraseq ctDNA Mutation Mix v4 AF5% is a refined reference material that accelerates validation of Next Generation Sequencing (NGS) assays for circulating tumor DNA. With 93 clinically relevant variants across 71 genes, it enables precise detection of low variant allele frequencies, reducing background noise and eliminating additional DNA isolation steps. Its formulation as purified DNA solution ensures readiness for NGS workflows, making it a reliable choice for clinical genomics.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.